Migraine Trial, Recruiting NCT06788977 Sponsor: Cefaly Technology Condition: Migraine
Back to Migraine

Migraine Trial, Recruiting

NCT06788977
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing and able to give simple consent to take part in a registry.
  • People who have access to email or text messages through a smartphone or computer with internet.
  • People who are between 18 and 44 years old at the time of joining.
  • People who are pregnant with one baby (not twins or more) at the time of joining.
  • People who had headaches or migraines before pregnancy and these continued into pregnancy, or whose headaches or migraines started during the first three months of pregnancy.
  • People who can upload proof of an active pregnancy and an estimated due date — accepted documents include an ultrasound report, a beta hCG lab result, or a signed note from a healthcare provider confirming the pregnancy and due date.

Who may not be able to join:

  • People who are younger than 18 or older than 44 at the time of joining.
  • People who are not currently pregnant at the time of joining.
  • People who are pregnant with more than one baby (such as twins or triplets) at the time of joining.
  • People whose doctor or the trial's lead researcher believes another health condition may prevent safe participation.
  • People who do not have access to email, a smartphone, or a computer with internet.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Deena Kuruvilla, MD

Phone: 203-309-3776

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Cefaly Technology
Registry
ClinicalTrials.gov
Start date
25 November 2024
Est. completion
1 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Rate of miscarriage per trimester; Postpartum Bonding according to the Maternal-to-Infant Bonding Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov